Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
Elisabeth F.P. Peterse(Leiden University Medical Center), Judith V.M.G. Bovée(Leiden University Medical Center)
Cited by 61
Related Papers
Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
|Oncogenesis|2018|57
Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone
|BMC Cancer|2012|43
Targeting survivin as a potential new treatment for chondrosarcoma of bone
|Oncogenesis|2016|34